Skip to content

EFFECT OF AYURVEDIC OINTMENT IN INFECTED WOUND

A RANDOMIZED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF TRIPHALA EXTRACT OINTMENT IN DUSHTA VRANA WITH SPECIAL REFERENCE TO INFECTED WOUND

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040282
Enrollment
76
Registered
2022-02-14
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue Health Condition 2: T07- Unspecified multiple injuries

Interventions

Intervention1: Triphala extract ointment: 2 gm topical application during dressing once daily for 15 days Control Intervention1: Betadine ointment: 2 gm topical application during dressing once dail

Sponsors

Dr Umesh Babanrao Kapte
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient having clinical features of Nija or Agnatuj Dushta vrana i.e. foul Smell,pus discharge ,pain,burning sensation and edema. wound less than or equal to 10 cm2 of area. patient with all types of dushta vrana with maximum history of 1 month.

Exclusion criteria

Exclusion criteria: patient suffering from systemic disease like uncontrolled DM, TB ,CKD, Severe anaemia, malnutrition. patient suffering from grave condition like malignant ulcer and other severe illness like HIV. wound greater than 10 cm2 or depth greater than 1 cm. bone deep ulcer ,compound fracture and ischemic ulcer.

Design outcomes

Primary

MeasureTime frame
Reduction in sign and symptoms. Reduction in Size of woundTimepoint: 15 days

Secondary

MeasureTime frame
Cost Effective TreatmentTimepoint: 15 days

Countries

India

Contacts

Public ContactDrPankaj Dixit

A.S.S Ayurved mahavidyalaya,Panchavati,Nashik

drpankajpdixit@gmail.com9011045371

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026